Available via license: CC BY 3.0
Content may be subject to copyright.
Selection of our books indexed in the Book Citation Index
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us?
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected.
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International authors and editor s
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
116,000
120M
TOP 1%
154
3,900
Provisional chapter
Citrus and Health
Javier Marhuenda, Begoña Cerdá, Débora Villaño,
Alejandro Galindo and Pilar Zafrilla
Additional information is available at the end of the chapter
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
JavierMarhuenda, BegoñaCerdá, DéboraVillaño,
AlejandroGalindo and PilarZafrilla
Additional information is available at the end of the chapter
Abstract
Citrus has been proposed as an interesting ingredient in the elaboration of food products
as soft drinks due to its distinctive aroma and high nutritive value. It is a rich source
of nutrients that contains higher amounts of vitamin C, citric acid, minerals, and avo-
noids, especially avanones and avones (reaching values of 400–600 mg/L) and in lesser
amounts avonols and hydroxycinnamic acids. Citrus avonoids decrease capillary
permeability and are benecial in the treatment of vascular diseases. Scientic studies
suggest that the ingestion of food products based on citrus fruits improves the blood lipid
prole, reduces oxidative stress, prevents atherogenic modications of LDL and platelet
aggregation, as well as contributes to the improvement of HDL levels. Other benets
aributed to citrus are antiaging, anticancer, neuroprotective, and antidiabetic. The pres-
ent revision tries to empathize the most relevant studies regarding citrus and health.
Keywords: citrus, obesity, neurodegeneration, diabetes, cancer, cardiovascular diseases
1. Introduction
There are numerous evidences supporting the crucial inuence of diet in the prevention of
diseases related to oxidative and inammatory processes. Citrus are one of the most impor-
tant foods included in a healthy lifestyle, due to their composition in bioactive compounds.
The biological activity of citrus bioactive compounds is mainly their free radical scavenging
property, increasing the antioxidant activity which closely related to disease prevention.
Healthy properties of citrus have been linked to its high vitamin content C and avonoids,
mainly aributed to its antioxidant capacity. Citrus are considered adjuvant in the preven-
tion of cardiovascular diseases and metabolic diseases such as obesity, diabetes mellitus or
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
dyslipidemia, as well as certain types of cancer. In citrus (particularly lemon), more than 60
individual avonoids have been identied.
2. Citrus and their role in dierent pathologies
The health benets described with the consumption of these fruits are related to their complete
prole on nutrients, including simple sugars, ber, potassium, high contents of vitamin C and
phytochemicals as avonoids, particularly avanones that may act synergistically. They are
low in fat and proteins, ranging from 0.1 to 0.3 g and from 0.69 to 0.94 g/100 g fresh weight,
respectively. Citrus are particularly rich in vitamin C (ascorbic acid), providing amounts in the
range of 23–83 g/100 g fresh weight. Considering that the Recommended Dietary Allowance
(RDA) is set at 75–80 mg and a medium-sized orange or grapefruit contains from 50 to 70 mg
ascorbic acid, it is easy to provide the necessary quantities with these fruits in a daily dietary
paern [1].
Micronutrients are secondary metabolites synthesized in the plant as a defense mechanism
against pathogens, parasites, or to protect from UV radiation. We nd two main groups in
citrus fruits: terpenes and avanones.
Terpenes are present in the essential aromatic oil produced by cells in the avedo, and the
main compounds are limonene and citral (mixture of isomers geranial and neral) (Figure 1).
These volatile substances contribute to the avor of citrics; similar to the protection eect
against biotic stress in plants, they have shown antimicrobial activities interesting for food
preservation and medicinal purposes [2, 3].
Besides, citrus fruits are especially rich in the avanones hesperetin, naringenin, and eriodic-
tyol [4]. Flavanones have the characteristic 15-carbon backbone ring structure common in the
avonoids (C6▬C3▬C6), consisting of two aromatic rings linked by three carbon atoms in an
oxygenated structure as pirane derivative [5]. In particular, avanones have a further degree
of oxidation, with a ketone group at position C-4 in C-ring.
These compounds are mainly found glycosylated, with a disaccharide linked by glycosidic
bond; common positions are the hydroxyl groups of C3 and C7. The free form (aglycone)
can render dierent avanones, depending on the position and type of sugar linked. In this
sense, grapefruit is abundant in narirutin and naringin, which are both heterosides from
the aglycone naringenin, but the glucose moiety is dierent (rutinoside or neohesperoside,
respectively). Orange is rich in hesperidin, that is the glycoside of hesperetin, while lemon is
rich in eriocitrin that contains the aglycone eriodictyol [6].
Flavanones are not uniformly distributed in the fruit but are more abundant in the albedo.
Because this part is discarded in juice processing, the level of avanones is lower in citrus
juices than in the whole fresh fruit [7]. In fact, levels of in orange fruit range between 35
and 147 mg/100 g of total avanones and 44 and 106 mg/100 g of naringin and narirutin
Citrus - Health Benefits and Production Technology2
Figure 1. Chemical structures of the main terpenes present in citrus essential oil.
Citrus and Health 3
in grapefruit [8]. By contrast, orange and grapefruit juices showed values between 10 and
80 mg/100 g of hesperidin and narirutin [9] and naringenin [10]. Therefore, the paern of
consumption of these fruits greatly aects the avanone total intake and further biological
activities. Moreover, the sugar moiety modies the in vivo pharmacokinetic properties of the
compound. Aglycones are more easily absorbed than their heterosides counterparts, as gly-
cosides are more hydrophilic and need active transport by proteins in gastrointestinal lumen
and/or hydrolysis by gut microora in order to be absorbed [11].
2.1. Citrus and cancer
Flavonoids are major compounds in citrus, and have been investigated since more than
20 years ago. Dietary avonoids have showed to be able to exert chemopreventive or anti-
cancer capacity [12]. Anticancer capacity of citrus avonoids takes place through three main
mechanisms: defense against DNA injury, inhibition of tumor growth, and inhibition of cell
proliferation [13].
The best anticancer compound must exert the most possible inhibition of tumor growth or
to able to destroy cancer cells, but origins minimum adverse health collateral eects [14].
Flavonoids are natural and considered innocuous and great compounds for the treatment of
cancerous processes [15, 16]. The synthetic molecules that can be used for the treatment of can-
cer are extremely noxious, and can be able to destroy healthy cells. Due to the safe long-term
consumption of avonoids, and their innate biological activity, avonoids can be considered
as good applicants regarding cancer treatment. In fact, scientic literature has revealed cyto-
toxic eects of citrus avonoids on cancer cells, with slightest adverse health eects.
That fact has led the research in order to implement avonoid-based cancer treatments [17].
As other polyphenols, the presence of aromatic rings in avonoids leads to pro- and antioxi-
dant capacity that can be useful for chemotherapies [18]. Cancerous cells show an increment
on oxidative stress, which leads to the possibility to be aacked by a substance that improves
reactive oxygen species level as avonoids do [19, 20]. As dened by Pacico et al. [21], pro- or
antioxidant capacity of citrus avonoids is dependent on the concentration, type of cell, and
culture condition (in vitro models).
Flavonoids exert DNA protection by their ability to absorb ultraviolet light. Some experiments
on a UV-irradiated model of plasmidic DNA indicate protecting capacity of naringenin and
rutin against UV-induced damage of DNA [22]. Indeed, naringin plays an important role in
regulating antioxidative capacity by increasing superoxide dismutase and catalase activities
and by upregulating the gene expressions of superoxide dismutase, catalase, and glutathione
peroxidase in cholesterol-rich diet-fed rabbits [23].
Apart from UV protection, avonoids can also diminish tumor promotion at the beginning of
carcinogenesis by the intensication of the detoxication processes. In particular, citrus avo-
noids inhibit ornithine decarboxylase induction of skin tumor promotion, activating protein
kinase C [24, 25]. Miller et al. [26] studied the inhibition of oral carcinogenesis by citrus avo-
noids in hamsters and the antineoplastic activity, concluding that hesperetin, neohesperetin,
tangeretin, and nobiletin were ineective, while naringin and naringenin gave good results.
Citrus - Health Benefits and Production Technology4
Citrus avonoids can inhibit invasion, by rat malignant cells, in cardiac and hepatic tissue of
syngenetic rats [27]. Hydroxycinnamates, glycosylated avonoids, and the polymethoxylated
avones have shown inhibitory activity on several tumoral cell line proliferations [13]. Other
studies showed eriocitrin and its aglycone, eriodictyol, as potent inhibitors of lipoxygenases,
which are involved in the biosynthesis of various bioregulators that are closely related to
the pathogenesis of several diseases such as allergy and atherosclerosis and cancer [28].
Hesperidin in dierent citrus juices also showed antiproliferative activity [29], reporting
lemon in particular potent antiproliferative activities on HepG2 human liver-cancer cell in a
dose-dependent manner [30].
Also, the positive eect of vitamin C in reducing the incidence of stomach cancer has been
studied, being most probably due to the inhibitory action in the generation of nitrous com-
pounds by interrupting the reaction between nitrites and amine groups [31], although it has
recently shown that this eect may be due to a cytotoxic eect of vitamin C on human gastric
cancer cell line AGS [32]. Consistent protective eect of vitamin C has also been found in lung
and colorectal cancer [33].
One stretched revision done by Turati [34] reported a diminution on cancers of the digestive
tract and larynx regarding high intake of citrus. That eect was found to be due to the content
on vitamin C, avanones, and other compounds with antioxidant, antimutagenic, and antip-
roliferative properties [35]. Subjects consuming more than one portion of citrus fruit per week
showed OR between 0·42 and 0·82 for oral cavity and pharyngeal cancer, esophageal cancer,
stomach cancer, colorectal cancer, and laryngeal cancer. However, despite the good results
obtained, no correlation was found for other neoplasms, including cancers of breast, ovary,
endometrium, prostate, or kidney [35].
The most recent and huge research about citrus and cancer was published in 2016. An adap-
tive meta-analysis of cohort studies revealed that regular dietary intake of citrus prevents the
development of gastric cancer, particularly cardia gastric cancer [36].
2.2. Citrus and cardiovascular diseases
Cardiovascular diseases (CVD) are one of the main causes of illness and death in Western
countries, and cardiovascular drugs are the most commonly used medications. There are two
types of factors involved in the development of CVD. Some factor can be modied, like life
style, diet, environment, or smoking. Other cannot be modied: genetic factors, gender, his-
tory, or age. Atherosclerotic plaque formation is the most common phenomenon involved in
CVD [37].
Consumption of citrus is inversely associated with incidence of CVD, due to the presence of
bioactive compounds like avonoids. Current research has focused on diet containing bioac-
tive compounds, as an alternative to pharmaceutical medication. It can be concluded from the
analysis of multiple studies that as the mean consumption of avonoids increases, mortality
due to CVD decreases. Epidemiological evidence of clinical and preclinical studies suggest
that avanones present in the citrus fruits positively inuence cardiac and metabolic param-
eters, preventing CVD [38].
Citrus and Health 5
A study performed on approximately 70.000 women highlighted an inverse correlation
between the intake of avanones and the risk of suering a cerebral ischemia, which is sig-
nicantly dierent when contemplate women who consume high levels of avanones [39].
Another recent meta-analysis study of three randomized clinical trials, including 233 patients,
demonstrated a correlation between avanones intake and a reduction in blood pressure [40].
Another recognized cardiovascular risk factor is metabolic syndrome, characterized by
altered glucose metabolism, elevated blood pressure, dyslipidemia, and obesity. In 2016, a
study on 10,000 subjects demonstrated an inverse association between polyphenols and meta-
bolic syndrome, which was particularly signicant in individuals with the highest intake of
polyphenols [41].
Several studies carried out so far support a preventive role of citrus fruits on the main risk
factors of CVD, such as hypertension, dyslipidemia, overweight, and hyperglycemia. Among
CVDs, the eect of avonoids on stroke is not clear. Mursu et al. [42] studied the association
between intake of avonoid and risk of stroke and mortality caused by stroke and concluded
that a greater intake of avonoids decreases the chances of ischemic stroke as well as mortal-
ity caused by CVD.
Chronic inammation is caused by the excessive production of chemokines and cytokines.
Cytokines and chemokines act as regulatory proteins under normal physiological conditions,
but their excessive production disrupts the gradient balance and more reactive oxygen species
(ROS) are produced. It has been shown that the grape avonoids control chronic inamma-
tion by reducing ROS level and by modulating pathways of inammation. As avonoids are
natural compounds, they can target multiple steps in the inammation pathway as compared
to monotargeted synthetic anti-inammatory drugs [43].
Atherosclerosis, characterized by the plaque formation in arteries, is one of the major factors
contributing to incidence of stroke and myocardial infarction. It is caused by high level of
lipoprotein and cholesterol in plasma [37]. High intake of citrus avonoids reduces several
risk factors for development of atherosclerosis including: high tolerance to glucose, maintain-
ing good body mass index, and lowering blood pressure [44].
In another study, patients with metabolic syndrome had reduced cholesterol and ApoB due
to the intake of a supplement of hesperidin for 3 weeks [45]. Furthermore, in a 2012 clinical
study performed in our laboratory on patients with metabolic syndrome diagnosed, after 4 or
6 months drinking a citrus fruit juice, the glycemic prole was unchanged but the lipid prole
improved, as observed by decrease in the cholesterol, LDL-C, and C-reactive protein [46].
Naringenin plays an important role to overcome the metabolic problem that is connected to
dyslipidemia and resistance to insulin. It was shown to prevent atherosclerosis development
in mice fed a high fat diet. Naringenin treatment aenuated the adverse eects caused by
hyperinsulinemia and hyperlipidemia which was induced by western style diet. In mice that
were fed a western diet, hyperlipidemia led to development of atherosclerosis in the aortic
sinus evidenced by the development of plaque is that increased 10 times as compared to chow-
fed animals. Naringenin treatment decreased the incidence of atherosclerosis by 70% [44].
Citrus - Health Benefits and Production Technology6
A clinical study with 500 mg of naringin plus 800 mg of hesperidin did not show a signi-
cant improvement in the lipid prole in patients with moderate hypercholesterolemia. This
study suggests that citrus avonoids have no eect on LDL-C in humans, at least not when
consumed in a capsule format [47]. A plausible explication of this results could be the inter-
individuals variability of pharmacokinetic parameters. Despite preclinical results are clearer,
further clinical studies need to be performed.
2.3. Citrus and diabetes
Diabetes is a chronic disease in which metabolic alterations of multiple etiologies character-
ized by chronic hyperglycemia and disorders in the metabolism of carbohydrates, fats, and
proteins occur. These alterations are the result of defects in the secretion of insulin, in the
action itself or in both. The long-term manifestation of insulin results in damage and dysfunc-
tion of various organs like nerves, kidneys, eyes, blood vessels, and heart. People living with
diabetes have a higher risk of morbidity and mortality than the general population [48].
Diabetes is an important public health problem, one of four priority noncommunicable dis-
eases (NCDs) targeted for action by world leaders. Both the number of cases and the preva-
lence of diabetes have been steadily increasing over the past few decades [49].
A recent report on diabetes by the World Health Organization estimates that 422 million cases
in 2014 [49], and an expected number of nearly 650 million subjects in 2040 was estimated [48].
This dramatic rise is largely due to type 2 diabetes (T2D).
The treatment of diabetes consists of pharmacological, dietary, and lifestyle measures. Many
trials have eectively tested dierent lifestyle and pharmacological intervention methods
both in terms of prevention and treatment [50].
The use of plants with antidiabetic properties is widely known and described in the scientic
literature. A lot of studies have reported that either plant parts or extracts of plant parts pos-
sess antidiabetic properties. This antidiabetic activity of plants is due to the presence of phy-
tochemicals which are termed as avonoids. In this way, several studies reported antidiabetic
activities of avonoids [51, 52].
Citrus fruits are one of the most consumed fruits mainly as fresh or raw materials for juices.
Additionally, citrus fruits can also be used in the food, beverage, cosmetic, and pharmaceuti-
cal industries [53].
Citrus fruits show several bioactivities of vital importance to human health, like antioxidative
and anti-inammatory activity, cardiovascular protective eects, antidiabetic activity, among
others. Citrus species contain a number of secondary metabolites, such as avonoids, alka-
loids, coumarins, limonoids, carotenoids, phenol acids, and essential oils [53]. Of all of them,
avonoids (especially avanone, avanonol, and methoxylated avones) are more active
compared to other secondary metabolites in citrus for their remarkable various bioactivities.
There are a lot of studies where have been widely reported on plentiful bioactivities from
avonoids.
Citrus and Health 7
Flavonoids, a group of natural substances with variable phenolic structures, are well known
for their benecial eects on health. Flavonoids are now considered as an indispensable com-
ponent in a variety of nutraceutical, pharmaceutical, medicinal, and cosmetic applications
[54]. Flavonoids are distinct based on structural characteristics in the following six subclasses:
avonols, avones, isoavones, avanones, anthocyanins, and avanols (catechins and pro-
anthocyanidins) [6]. In Citrus genus, avanones comprise approximately 95% of the total
avonoids, and these foods are the main source of avanones [6].
Citrus avanones are glycosylated in vegetables. The same aglycone can be combined with
several glycosides to give dierent avanones; for example, the most representative a-
vanones in grapefruit are narirutin and naringin, those in orange fruit are hesperidin and
narirutin, and that in lemon is eriocitrin [6]. Naringin, naringenin, nobiletin, narirutin, and
hesperidin are the most important avonoids thus far isolated from citrus fruits [35].
There has been a substantial body of evidence suggesting that oxidative stress is a key
mechanism in pathogenesis of diabetes. Flavanones and avanones-rich botanical extracts
have been a subject of great interest for scientic research. Citrus avanones like naringin
and hesperidin exert a variety of biological activities such as antioxidant, anti-inammatory,
antihyperglycemic, antiapoptotic, etc. Naringin and hesperidin along with their respective
aglycones, naringenin, and hesperetin have been shown to aenuate diabetes and its related
complications [55]. In this way, Ashafaq et al. [56] demonstrated that hesperidin treatment
signicantly aenuated the altered levels of oxidative stress and neurotoxicity biomarkers.
Their results demonstrate that hesperidin exhibits potent antioxidant and neuroprotective
eects on the brain tissue against the diabetic oxidative damage in STZ-induced rodent model.
Iskuender et al. observed that after administration of hesperidin and quercetin in STZ-induced
diabetic rats, glucose levels increased and liver and kidney damage markers decreased sig-
nicantly [57]. In the same way, Akiyama et al. [50] demonstrated that hesperidin normalizes
blood glucose by altering the activity of glucose-regulating enzymes, and lowering serum and
liver lipid levels in STZ-induced marginal type 1 diabetic rats without any body weight loss
due to STZ injection. Thus, hesperidin showed both hypoglycemic and hypolipidemic eects.
In a study, Gupta et al. [58] demonstrate the dipeptidyl peprtidase-4 (DPP-4) inhibition activ-
ity of citrus bioavonoid nutraceuticals as compared to known gliptins (oral antidiabetic
agents). The naringin and hesperidin compounds have the best individual activity in com-
parison to that of the gliptins. Natural gliptin-like alternatives may make these supplements a
promising group of natural products for use in improving blood glucose levels in prediabetes
and early stages of type 2 diabetes.
The hypoglycemic eect of naringin and naringenin is very well documented in animal and
cell studies. So, naringin (30 mg/kg) and vitamin C (50 mg/kg) cotreatment ameliorated strep-
tozotocin-induced diabetes in rats by improving insulin concentration and prevented oxida-
tive stress [59]. Naringenin supplementation (0.2 g/kg of diet) improved glucose intolerance
and insulin resistance in a model of high-fat-diet-fed mice [59]. More research is needed to
determine the mechanism by which naringenin has hypoglycemic eect. So far, some authors
have suggested the following: that is mediated via uptake of glucose in the skeletal muscle
[60]; increased activities of hexokinase [61]; decreased production and expression of IL-1b,
IL-6, and MCP-1 [62].
Citrus - Health Benefits and Production Technology8
Rutin is another avonoid present in citrus fruits to which many biological activities have
been aributed, among them having antihyperglycemic properties. In 2017, Ghorbani [63] in
a review discussed the antihyperglycemic property of rutin. Proposed mechanisms for this
eect include a decrease of carbohydrates absorption from the small intestine, inhibition of
tissue gluconeogenesis, an increase of tissue glucose uptake, stimulation of insulin secretion
from beta cells, and protecting Langerhans islet against degeneration. Rutin also decreases
the formation of sorbitol, reactive oxygen species, advanced glycation end product precur-
sors, and inammatory cytokines.
In conclusion, it can be armed that avonoids are useful in the prevention and treatment of
diabetes, especially in diabetes type 2, as Xu et al. [64] arm the meta-analysis of prospective
cohort studies carried out in 2018. Now, more studies are needed to elucidate the mechanism
or mechanisms by which they carry out this antidiabetic activity.
2.4. Citrus and neurodegenerative diseases
Neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease
represent rapidly growing causes of disability and death, which have profound economic and
social implications; nonetheless, only few eective disease-modifying therapies are available
for these diseases [65, 66].
Citrus avonoids exert lile adverse eect and have low or no cytotoxicity to healthy, nor-
mal cells. The main citrus avonoids can also traverse the blood-brain barrier; hence, they
are promising candidates for intervention in neurodegeneration and as constituents in brain
foods [67].
Assessment of cognitive performance in middle-aged individuals has indicated that con-
sumption of dierent polyphenols such as catechins, avonols, and hydroxybenzoic acids is
strongly associated with language and verbal memory. Hydroxycinnamates, phenolic acids,
and phenolic alcohol are also capable of inducing neuroprotective eects in the same way as
avonoids [68].
Naringenin and hesperidin are abundant polyphenols in citrus fruits and have been shown to
have protective eects in Huntington’s disease due to their mechanism of nitric acid against
3-nitropropionic acid, which presents neurotoxicity in experimental models with rats [69].
5-Hydroxy-3,6,7,8,3′,4′-hexamethoxyavone (HHMF) from the Citrus genus and nobiletin,
the most abundant polymethoxyavone in orange peel extract are compounds that enhance
neuronal survival and exerted prosurvival action in PC12 cells [70].
Ushikubo et al. [71] demonstrated that 3,3′,4′,5,5′-pentahydroxyavone prevents Aβ bril for-
mation and that lowering bril formation decreases Aβ-induced cell death in rat hippocampal
neuronal cells. In another study, ursolic acid, p-coumaric acid, and gallic acid extracted from
Corni fructus plant were shown to aenuate apoptotic features such as morphological nuclear
changes, DNA fragmentation, and cell blebbing induced by Aβ peptide in PC12 cells [72].
The citrus avanones hesperidin, hesperetin, and neohesperidin are known to exhibit anti-
oxidant activities and could traverse the blood-brain barrier [73]. These authors showed
that hesperetin, hesperidin, and neohesperidin inhibited the decrease of cell viability (MTT
Citrus and Health 9
reduction), prevented membrane damage (LDH release), scavenged ROS formation, increased
catalase activity, and aenuated the elevation of intracellular free Ca2+, the decrease of mito-
chondrial membrane potential and the increase of caspase-3 activity in H2O2-induced PC12
cells. Meanwhile, hesperidin and hesperetin aenuated decreases of glutathione peroxidase
and glutathione reductase activities and decreased DNA damage in H2O2-induced PC12 cells.
These results rst demonstrate that the citrus avanones, such as hesperidin, hesperetin, and
neohesperidin, even at physiological concentrations, have neuroprotective eects against
H2O2-induced cytotoxicity in PC12 cells. These dietary antioxidants are potential candidates
for use in the intervention for neurodegenerative diseases.
Antunes et al. [74] demonstrated that hesperidin (50 mg/kg) treatment was eective in
preventing memory impairment in the Morris water maze test, as well as depressive-like
behavior in the tail suspension test. Hesperidin aenuated the 6-OHDA-induced reduction
in glutathione peroxidase and catalase activity, total reactive antioxidant potential, and the
dopamine and its metabolite levels in the striatum of aged mice. This study demonstrated a
protective eect of hesperidin on the neurotoxicity induced by 6-OHDA in aged mice, indicat-
ing that it could be useful as a therapy for the treatment of PD.
Chakraborty et al. [75] showed that hesperidin completely inhibits the amyloid bril forma-
tion which is further supported by atomic force microscopy. Hesperidin exhibited moderate
ABTS(+) radical scavenging assay but strong hydroxyl radical scavenging ability, as evident
from DNA nicking assay.
3. Conclusions
The Mediterranean diet, considered a good example of a prudent and healthy diet, has under-
gone important changes in recent years. Factors such as urbanization, pollution, economic
development, excessive working hours, and the adoption of inadequate lifestyles cause the
population to be exposed to environmental and nutritional factors associated with the onset
and progression of diseases related to aging. In this sense, citrus fruits are an important source
of bioactive compounds, powerful antioxidants whose health benets have been scientically
demonstrated in several studies for their protective role against oxidative damage. For this
reason, the regular consumption of citrus fruits should be promoted as part of a varied and
balanced diet. The absence of sucient scientic evidence and validated tests to reliably mea-
sure the antioxidant activity in vivo of the bioactive compounds present in citrus justies the
need of interventional studies in humans for the correct determination of bioactive properties
of citrus and their bioactive compounds.
Conict of interest
Authors declare that they do not have conict of interest.
Citrus - Health Benefits and Production Technology10
Author details
Javier Marhuenda*, Begoña Cerdá, Débora Villaño, Alejandro Galindo and Pilar Zafrilla
*Address all correspondence to: jmarhuenda@ucam.edu
Faculty of Health Sciences, Department of Pharmacy, UCAM, Murcia, Spain
References
[1] Liu Y, Heying E, Tanumihardjo SA. History, global distribution, and nutritional impor-
tance of citrus fruits. Comprehensive Reviews in Food Science and Food Safety. 2012;11:
530-545
[2] Aliberti L, Caputo L, De Feo V, De Martino L, Nazzaro F, Souza LF. Chemical composi-
tion and in vitro antimicrobial, cytotoxic, and central nervous system activities of the
essential oils of Citrus medica L. cv.“Liscia”and C. Medica cv.“Rugosa”cultivated in
southern Italy. Molecules. 2016;21:1244
[3] Hsouna AB, Halima NB, Smaoui S, Hamdi N. Citrus lemon essential oil: Chemical
composition, antioxidant and antimicrobial activities with its preservative eect against
listeria monocytogenes inoculated in minced beef meat. Lipids in Health and Disease.
2017;16:146
[4] Spigoni V, Mena P, Fantuzzi F, Tassoi M, Brighenti F, Bonadonna RC, Del Rio D, Dei
Cas A. Bioavailability of bergamot (Citrus bergamia) avanones and biological activity of
their circulating metabolites in human pro-angiogenic cells. Nutrients. 2017;9:1328
[5] Mir IA, Tiku AB. Chemopreventive and therapeutic potential of “naringenin,” a ava-
none present in citrus fruits. Nutrition and Cancer. 2015;67:27-42
[6] Testai L, Calderone V. Nutraceutical value of citrus avanones and their implications in
cardiovascular disease. Nutrients. 2017;9:502
[7] Escobedo-Avellaneda Z, Gutiérrez-Uribe J, Valdez-Fragoso A, Torres JA, Welti-Chanes J.
Phytochemicals and antioxidant activity of juice, avedo, albedo and comminuted
orange. Journal of Functional Foods. 2014;6:470-481
[8] Peterson JJ, Dwyer JT, Beecher GR, Bhagwat SA, Gebhardt SE, Haytowi DB, Holden JM.
Flavanones in oranges, tangerines (mandarins), tangors, and tangelos: A compilation
and review of the data from the analytical literature. Journal of Food Composition and
Analysis. 2006;19:S66-S73
[9] Tomás-Barberán FA, Cliord MN. Flavanones, chalcones and dihydrochalcones–
nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture.
2000;80:1073-1080
Citrus and Health 11
[10] Ross SA, Ziska DS, Zhao K, ElSohly MA. Variance of common avonoids by brand of
grapefruit juice. Fitoterapia. 2000;71:154-161
[11] Urpi-Sarda M, Rothwell J, Morand C, Manach C. Bioavailability of Flavanones. New York,
NY, USA: CRC Press; 2012
[12] Hertog MG, Feskens EJ, Kromhout D, Hollman P, Katan M. Dietary antioxidant avo-
noids and risk of coronary heart disease: The Zutphen elderly study. The Lancet. 1993;
342:1007-1011
[13] Manthey JA, Guthrie N, Grohmann K. Biological properties of citrus avonoids pertain-
ing to cancer and inammation. Current Medicinal Chemistry. 2001;8:135-153
[14] Zhao Y, Wang J, Ballevre O, Luo H, Zhang W. Antihypertensive eects and mechanisms
of chlorogenic acids. Hypertension Research. 2012;35:370-374
[15] Szliszka E, Helewski KJ, Mizgala E, Krol W. The dietary avonol setin enhances the
apoptosis-inducing potential of TRAIL in prostate cancer cells. International Journal of
Oncology. 2011;39:771-779
[16] Yoshimizu N, Otani Y, Saikawa Y, Kubota T, Yoshida M, Furukawa T, Kumai K, Kame-
yama K, Fujii M, Yano M. Anti-tumour eects of nobiletin, a citrus avonoid, on gastric
cancer include: Antiproliferative eects, induction of apoptosis and cell cycle deregula-
tion. Alimentary Pharmacology and Therapeutics. 2004;20:95-101
[17] Sak K. Cytotoxicity of dietary avonoids on dierent human cancer types. Pharmacognosy
Reviews. 2014;8:122-146. DOI: 10.4103/0973-7847.134247
[18] Leung HW, Lin CJ, Hour MJ, Yang WH, Wang MY, Lee HZ. Kaempferol induces apop-
tosis in human lung non-small carcinoma cells accompanied by an induction of anti-
oxidant enzymes. Food and Chemical Toxicology. 2007;45:2005-2013. DOI: 10.1016/j.
fct.2007.04.023
[19] Valdameri G, Trombea-Lima M, Worfel PR, Pires ARA, Martinez GR, Noleto GR,
Cadena SMSC, Sogayar MC, Winnischofer SMB, Rocha MEM. Involvement of catalase
in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells.
Chemico-Biological Interactions. 2011;193:180-189. DOI: 10.1016/j.cbi.2011.06.009
[20] Yuan L, Wang J, Xiao H, Xiao C, Wang Y, Liu X. Isoorientin induces apoptosis through
mitochondrial dysfunction and inhibition of PI3K/Akt signaling pathway in HepG2
cancer cells. Toxicology and Applied Pharmacology. 2012;265:83-92. DOI: 10.1016/j.
taap.2012.09.022
[21] Pacico S, Scognamiglio M, D’Abrosca B, Piccolella S, Tsafantakis N, Gallicchio M, Ricci A,
Fiorentino A. Spectroscopic characterization and antiproliferative activity on HepG2 human
hepatoblastoma cells of avonoid C-glycosides from Petrorhagia velutina. Journal of Natural
Products. 2010;73:1973-1978. DOI: 10.1021/np100255u
[22] Kootstra A. Protection from UV-B-induced DNA damage by avonoids. Plant Molecular
Biology. 1994;26:771-774
Citrus - Health Benefits and Production Technology12
[23] Jeon SM, Bok SH, Jang MK, Lee MK, Nam KT, Park YB, Rhee SJ, Choi MS. Antioxidative
activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sciences. 2001;
69:2855-2866
[24] Manach C, Regerat F, Texier O, Agullo G, Demigne C, Remesy C. Bioavailability, metab-
olism and physiological impact of 4-oxo-avonoids. Nutrition Research. 1996;16:517-544
[25] Miller E. Neurodegenerative diseases. Advances in Experimental Medicine and Biology.
2012;724:228-238
[26] Miller EG, Peacock JJ, Bourland TC, Taylor SE, Wright JM, Patil BS, Miller EG. Inhibition
of oral carcinogenesis by citrus avonoids. Nutrition and Cancer. 2007;60:69-74
[27] Bracke ME, Vyncke BM, Van Larebeke NA, Bruyneel EA, De Bruyne GK, De Pestel GH,
De Coster WJ, Espeel MF, Mareel MM. The avonoid tangeretin inhibits invasion of MO
4 mouse cells into embryonic chick heartin vitro. Clinical and Experimental Metastasis.
1989;7:283-300
[28] Nogata Y, Ohta H, Ishii T, Sekiya K. Isolation of eriocitrin (eriodictyol 7-O-rutinoside) as
an arachidonate lipoxygenase inhibitor from Lumie fruit (citrus lumia) and its distribu-
tion in citrus species. Journal of the Science of Food and Agriculture. 2007;87:82-89
[29] Camarda L, Di Stefano V, Del Bosco SF, Schillaci D. Antiproliferative activity of citrus
juices and HPLC evaluation of their avonoid composition. Fitoterapia. 2007;78:426-429
[30] Sun J, Chu Y-F, Wu X, Liu RH. Antioxidant and antiproliferative activities of common
fruits. Journal of Agricultural and Food Chemistry. 2002;50:7449-7454
[31] You W, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, Li JY, Jin ML, Hu YR, Yang CS,
Blaser MJ, Correa P, Blot WJ, Fraumeni JF Jr, Xu GW. Gastric dysplasia gastric cancer
helicobacter pylori serum Vitam. C risk factors. Journal of the National Cancer Institute.
2000;92:1607-1612
[32] Nagappan A, Park KI, Park HS, Kim JA, Hong GE, Kang SR, Lee DH, Kim EH, Lee WS,
Won CK. Vitamin C induces apoptosis in AGS cells by down-regulation of 14-3-3σ via a
mitochondrial dependent pathway. Food Chemistry. 2012;135:1920-1928
[33] Kojo S. Vitamin C: Basic metabolism and its function as an index of oxidative stress.
Current Medicinal Chemistry. 2004;11:1041-1064
[34] Turati F, Rossi M, Pelucchi C, Levi F, La Vecchia C. Fruit and vegetables and can-
cer risk: A review of southern European studies. The British Journal of Nutrition.
2015;113:S102-S110. DOI: 10.1017/S0007114515000148
[35] Foschi R, Pelucchi C, Dal Maso L, Rossi M, Levi F, Talamini R, Bosei C, Negri E, Serraino D,
Giacosa A. Citrus fruit and cancer risk in a network of case–control studies. Cancer Causes
and Control. 2010;21:237-242
[36] Bae JM, Kim EH. Dietary intakes of citrus fruit and risk of gastric cancer incidence: An
adaptive meta-analysis of cohort studies. Epidemiology and Health. 2016;38
Citrus and Health 13
[37] Mendis S, Puska P, Norrving B, World Health Organization. Global Atlas on Cardio-
vascular Disease Prevention and Control. Geneva: World Health Organization; 2011.
ISBN 92-4-456437-8
[38] Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of
stroke a meta-analysis of cohort studies. Neurology. 2005;65:1193-1197
[39] Cassidy A, Rimm EB, O’reilly EJ, Logroscino G, Kay C, Chiuve SE, Rexrode KM. Dietary
avonoids and risk of stroke in women. Stroke. 2012;43:946-951
[40] Onakpoya I, O’Sullivan J, Heneghan C, Thompson M. The eect of grapefruits (Citrus
paradisi) on body weight and cardiovascular risk factors: A systematic review and meta-
analysis of randomized clinical trials. Critical Reviews in Food Science and Nutrition.
2017;57:602-612
[41] Grosso G, Stepaniak U, Micek A, Steer D, Bobak M, Pająk A. Dietary polyphenols are
inversely associated with metabolic syndrome in polish adults of the HAPIEE study.
European Journal of Nutrition. 2017;56:1409-1420
[42] Mursu J, Voutilainen S, Nurmi T, Tuomainen T-P, Kurl S, Salonen JT. Flavonoid intake
and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: The
Kuopio Ischaemic heart disease risk factor study. The British Journal of Nutrition. 2008;
100:890-895
[43] Sung B, Prasad S, Gupta SC, Patchva S, Aggarwal BB. Regulation of inammation-medi-
ated chronic diseases by botanicals. In Advances in Botanical Research, Elsevier 2012;
Vol. 62: pp. 57-132 ISBN 0065-2296
[44] Mulvihill EE, Hu MW. Antiatherogenic properties of avonoids: Implications for car-
diovascular health. The Canadian Journal of Cardiology. 2010;26:17A-21A
[45] Roohbakhsh A, Parhiz H, Soltani F, Rezaee R, Iranshahi M. Molecular mechanisms
behind the biological eects of hesperidin and hesperetin for the prevention of cancer
and cardiovascular diseases. Life Sciences. 2015;124:64-74
[46] Mulero J, Bernabé J, Cerdá B, García-Viguera C, Moreno DA, Albaladejo MD, Avilés F,
Parra S, Abellán J, Zafrilla P. Variations on cardiovascular risk factors in metabolic syn-
drome after consume of a citrus-based juice. Clinical Nutrition. 2012;31:372-377
[47] Demonty I, Lin Y, Zebregs YE, Vermeer MA, van der Knaap HC, Jäkel M, Trautwein EA.
The citrus avonoids hesperidin and Naringin do not aect serum cholesterol in
mod erately hypercholesterolemic men and women–3. The Journal of Nutrition. 2010;
140:1615-1620
[48] Marathe PH, Gao HX, Close KL. American Diabetes Association standards of medical
care in diabetes 2017. Journal of Diabetes. 2017;9:320-324
[49] Organization WH, Unit, W. H. O. M. of S. A. Global Status Report on Alcohol and Health,
2014; World Health Organization; 2014. ISBN 92-4-156475-X
[50] Akiyama S, Katsumata S, Suzuki K, Ishimi Y, Wu J, Uehara M. Dietary hesperidin exerts
hypoglycemic and hypolipidemic eects in streptozotocin-induced marginal type 1 dia-
betic rats. Journal of Clinical Biochemistry and Nutrition. 2009;46:87-92
Citrus - Health Benefits and Production Technology14
[51] Brahmachari G. Bio-avonoids with promising antidiabetic potentials: A critical sur-
vey. Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry.
2011;2:187-212
[52] Kaleem M, Ahmad A. Flavonoids as nutraceuticals. Therapeutic, Probiotic, and Uncon-
ventional Foods. 2018;137-155
[53] Lv X, Zhao S, Ning Z, Zeng H, Shu Y, Tao O, Xiao C, Lu C, Liu Y. Citrus fruits as a
treasure trove of active natural metabolites that potentially provide benets for human
health. Chemistry Central Journal. 2015;9:68
[54] Panche AN, Diwan AD, Chandra SR. Flavonoids: An overview. Journal of Nutritional
Science. 2016;5
[55] Sharma M, Akhtar N, Sambhav K, Shete G, K Bansal A, Sharma S. Emerging potential of
citrus avanones as an antioxidant in diabetes and its complications. Current Topics in
Medicinal Chemistry. 2015;15:187-195
[56] Ashafaq M, Varshney L, Khan MHA, Salman M, Naseem M, Wajid S, Parvez S. Neuro-
modulatory eects of hesperidin in mitigating oxidative stress in streptozotocin induced
diabetes. BioMed Research International. 2014;2014:249031
[57] Iskender H, Dokumacioglu E, Sen TM, Ince I, Kanbay Y, Saral S. The eect of hesperidin
and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimen-
tal diabetes model. Biomedicine and Pharmacotherapy. 2017;90:500-508
[58] Gupta A, Jacobson GA, Burgess JR, Jelinek HF, Nichols DS, Narkowicz CK, Al-Aubaidy
HA. Citrus bioavonoids possess dipeptidyl peptidase-4 inhibition activity similar to
gliptin antidiabetic medication. Biochemical and Biophysical Research Communications.
2018
[59] Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD. Eect of citrus
avonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of
action. Advances in Nutrition. 2014;5:404-417
[60] Jung UJ, Lee MK, Jeong KS, Choi MS. The hypoglycemic eects of hesperidin and nar-
ingin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db
mice. The Journal of Nutrition. 2004;134:2499-2503
[61] Punithavathi VR, Anuthama R, Prince PSM. Combined treatment with naringin and
vitamin C ameliorates streptozotocin-induced diabetes in male Wistar rats. Journal of
Applied Toxicology. 2008;28:806-813
[62] Annadurai T, Muralidharan AR, Joseph T, Hsu MJ, Thomas PA, Geraldine P. Antihy-
perglycemic and antioxidant eects of a avanone, naringenin, in streptozotocin–nico-
tinamide-induced experimental diabetic rats. Journal of Physiology and Biochemistry.
2012;68:307-318
[63] Ghorbani A. Mechanisms of antidiabetic eects of avonoid rutin. Biomedicine and
Pharmacotherapy. 2017;96:305-312
[64] Xu H, Luo J, Huang J, Wen Q. Flavonoids intake and risk of type 2 diabetes mellitus: A
meta-analysis of prospective cohort studies. Medicine (Baltimore). 2018;97
Citrus and Health 15
[65] Henry W, Querfurth HW, LaFerla FM. Mechanisms of disease Alzheimer’s disease. The
New England Journal of Medicine. 2010;362:329-344
[66] Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer’s disease:
Clinical trials and drug development. Lancet Neurology. 2010;9:702-716
[67] Hwang SJ, Kim YW, Park Y, Lee HJ, Kim KW. Anti-inammatory eects of chloro-
genic acid in lipopolysaccharide-stimulated RAW 264.7 cells. Inammation Research.
2014;63:81-90. DOI: 10.1007/s00011-013-0674-4
[68] Vauzour D, Corona G, Spencer JP. Caeic acid, tyrosol and p-coumaric acid are potent
inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Archives of Biochemistry
and Biophysics. 2010;501:106-111
[69] Kumar A, Kingdon E, Norman J. The isoprostane 8-iso-PGF2α suppresses monocyte
adhesion to human microvascular endothelial cells via two independent mechanisms.
The FASEB Journal. 2005;19:443-445
[70] Moosavi F, Hosseini R, Saso L, Firuzi O. Modulation of neurotrophic signaling path-
ways by polyphenols. Drug Design, Development and Therapy. 2016;10:23
[71] Ushikubo H, Watanabe S, Tanimoto Y, Abe K, Hiza A, Ogawa T, Asakawa T, Kan T,
Akaishi T. 3, 3′, 4′, 5, 5′-Pentahydroxyavone is a potent inhibitor of amyloid β bril
formation. Neuroscience Leers. 2012;513:51-56
[72] Hong SY, Jeong WS, Jun M. Protective eects of the key compounds isolated from
Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells. Molecules. 2012;
17:10831-10845
[73] Hwang SL, Shih PH, Yen GC. Neuroprotective eects of citrus avonoids. Journal of
Agricultural and Food Chemistry. 2012;60:877-885
[74] Antunes MS, Goes AT, Boeira SP, Prigol M, Jesse CR. Protective eect of hesperidin in a
model of Parkinson’s disease induced by 6-hydroxydopamine in aged mice. Nutrition.
2014;30:1415-1422
[75] Chakraborty S, Bandyopadhyay J, Chakraborty S, Basu S. Multi-target screening mines
hesperidin as a multi-potent inhibitor: Implication in Alzheimer’s disease therapeutics.
European Journal of Medicinal Chemistry. 2016;121:810-822
Citrus - Health Benefits and Production Technology16